Literature DB >> 9537334

Therapeutic angiogenesis in ischemic limbs.

J Folkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9537334     DOI： 10.1161/01.cir.97.12.1108

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  In vivo optical imaging of revascularization after brain trauma in mice.

Authors:  Yali Jia; Marjorie R Grafe; Andras Gruber; Nabil J Alkayed; Ruikang K Wang
Journal:  Microvasc Res       Date:  2010-11-12       Impact factor: 3.514

Review 2.  TOWARDS THE DEVELOPMENT OF NOVEL THERAPEUTICS FOR PERIPHERAL ARTERY DISEASE.

Authors:  Brian H Annex; George A Beller
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

3.  Inhibition of mini-TyrRS-induced angiogenesis response in endothelial cells by VE-cadherin-dependent mini-TrpRS.

Authors:  Rui Zeng; Yu-cheng Chen; Zhi Zeng; Xiao-xia Liu; Rui Liu; Ou Qiang; Xian Li
Journal:  Heart Vessels       Date:  2011-03-26       Impact factor: 2.037

4.  Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.

Authors:  Claudio Napoli; Sharon Williams-Ignarro; Filomena de Nigris; Gaetano de Rosa; Lilach O Lerman; Bartolomeo Farzati; Angelo Matarazzo; Giacomo Sica; Chiara Botti; Andrea Fiore; Russell E Byrns; Daigo Sumi; Vincenzo Sica; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

Review 5.  Cell therapy of peripheral arterial disease: from experimental findings to clinical trials.

Authors:  Zankhana Raval; Douglas W Losordo
Journal:  Circ Res       Date:  2013-04-26       Impact factor: 17.367

6.  A novel role for erythropoietin during fibrin-induced wound-healing response.

Authors:  Zishan A Haroon; Khalid Amin; Xiaohong Jiang; Murat O Arcasoy
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.

Authors:  M Meyer; M Clauss; A Lepple-Wienhues; J Waltenberger; H G Augustin; M Ziche; C Lanz; M Büttner; H J Rziha; C Dehio
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

8.  Gene therapy for myocardial angiogenesis: with direct intramuscular gene transfer of naked deoxyribonucleic acid encoding vascular endothelial growth factor and cell transplantation of vascular endothelial growth factor transfected H9c2 myoblast.

Authors:  Tsutomu Sugimoto; Kiyoshige Inui; Yasuhisa Shimazaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-05

Review 9.  Human studies of angiogenic gene therapy.

Authors:  Rajesh Gupta; Jörn Tongers; Douglas W Losordo
Journal:  Circ Res       Date:  2009-10-09       Impact factor: 17.367

10.  Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.

Authors:  Edward W Lee; Mieczyslaw Michalkiewicz; Joanna Kitlinska; Ivana Kalezic; Hanna Switalska; Peter Yoo; Amarin Sangkharat; Hong Ji; Lijun Li; Teresa Michalkiewicz; Milos Ljubisavljevic; Hakan Johansson; Derrick S Grant; Zofia Zukowska
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.